Low Testosterone treatment.
Low testosterone (hypogonadism) affects an estimated 40% of men over 45 and an increasing number of younger men due to environmental factors, chronic stress, and sleep disruption.
Start your consultWhat is low testosterone?
Low testosterone (hypogonadism) affects an estimated 40% of men over 45 and an increasing number of younger men due to environmental factors, chronic stress, and sleep disruption. Symptoms extend far beyond libido — impacting energy, cognition, muscle mass, bone density, and mood. KAYU uses comprehensive lab panels (total T, free T, SHBG, estradiol, LH, FSH) to diagnose accurately and prescribe bioidentical testosterone cypionate with ongoing monitoring.
Common signs of low testosterone.
Persistent fatigue and low energy
Reduced libido and sexual function
Loss of lean muscle mass
Increased body fat, especially visceral
Brain fog and difficulty concentrating
Irritability and mood changes
Poor sleep quality
Decreased bone density
How KAYU treats low testosterone.
KAYU physicians prescribe bioidentical testosterone cypionate via weekly subcutaneous or intramuscular injection, titrated to your lab results — not a generic dose. We monitor hematocrit, PSA, estradiol, and liver function at every lab draw. Many patients also benefit from adjunct therapies (DHEA, pregnenolone, anastrozole) based on their complete hormone panel.
Peptides for low testosterone.
CJC-1295 / Ipamorelin
Growth hormone release supports lean mass and recovery alongside TRT
BPC-157
Tissue repair and anti-inflammatory support
Peptide availability is subject to FDA regulatory status. Your KAYU physician will only prescribe molecules with current regulatory clearance. Withdrawn peptides are never included in KAYU protocols.
Related services
Ready to feel rooted?
Two minutes to the assessment. One week to your first consult. A protocol built on your bloodwork from a physician who knows your name.